Capecitabine Fresenius Kabi

Medicinal product

(Invented) name

Capecitabine Fresenius Kabi

Active substance (s)

Kapecitabinas

Strength

150 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01BC06, Capecitabine

Marketing authorisation holder

Fresenius Kabi Oncology Plc, Jungtinė Karalystė

Date of authorisation

2012-09-27

Date of renewal

Documents

3075_1 Capecitabine Frese Kabi_150 RPP keit.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

NL/H/2331/001/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Kapecitabinas	150 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
46274	60081	1060081	lizdinė plokštelė	N60		Receptinis	LT/1/12/3075/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2017-03-31	Išregistruotas
2012-09-27	Registruotas